Haleos Labs Ltd

NSE:HALEOSLABSHealthcare

₹1,538.30+0.39%At closeAt close · Mon 19 Oct · ≈ AED 59.43 · Market cap $48.27M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	15.4%	25.2%	27.1%	30.3%	34.8%	14.4%	—	—
Operating margin	9.3%	7.1%	5.8%	5.4%	8.9%	8.8%	8.8%	+0.0 pts
Net margin	5.1%	7.3%	3.7%	3.0%	6.0%	5.2%	7.5%	+2.4 pts
EBITDA margin	12.1%	13.9%	10.8%	11.6%	14.7%	13.4%	—	—
Return on equity	10.5%	16.6%	6.8%	5.1%	10.2%	8.1%	11.0%	+2.9 pts
Return on assets	4.4%	7.1%	2.9%	2.3%	5.2%	3.8%	5.5%	+1.7 pts
Return on capital employed	12.9%	11.1%	6.9%	6.6%	12.2%	9.8%	—	—
Debt / equity	0.5×	0.5×	0.6×	0.6×	0.4×	0.5×	0.5×	−7.0%
Debt / assets	21.3%	22.3%	25.4%	25.7%	22.2%	24.3%	—	—
Interest coverage	5.5×	4.3×	2.8×	1.6×	3.6×	4.5×	—	—
Current ratio	1.1×	1.2×	1.2×	1.1×	1.1×	1.0×	1.0×	+0.0%
Quick ratio	0.5×	0.5×	0.5×	0.5×	0.6×	0.5×	—	—
Cash ratio	0.1×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	0.9×	1.0×	0.8×	0.8×	0.9×	0.7×	—	—
Inventory turnover	3.3×	3.1×	2.6×	2.6×	3.3×	3.6×	—	—
Receivables turnover	5.8×	9.8×	6.7×	5.8×	4.9×	5.4×	—	—
Dividend payout	0.0%	1.8%	4.0%	5.0%	2.3%	2.6%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.